Stryker Corp. (SYK) Reports In-Line Q2 EPS; Guides FY11 Sales Growth
Tweet
Share
E-mailGet Alerts SYK Hot Sheet
Price: $339.21 -0.55%
Financial Fact:
Other income (expense): -67M
Today's EPS Names:
SVBT, ZEO, OTLK, More
Financial Fact:
Other income (expense): -67M
Today's EPS Names:
SVBT, ZEO, OTLK, More
Join SI Premium – FREE
Stryker Corp. (NYSE: SYK) reported Q2 EPS of $0.90, in-line with the analyst estimate of $0.90. Revenue for the quarter came in at $2.05 billion versus the consensus estimate of $2.01 billion.
Sees FY11 sales up 11 - 13 percent.
Sees FY11 sales up 11 - 13 percent.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Wolfe Research Downgrades Stryker (SYK) to Peerperform
- Tvardi Therapeutics (TVRD) Tops Q2 EPS by 1c
- Rein Therapeutics Inc. (RNTX) Tops Q2 EPS by 39c
Create E-mail Alert Related Categories
Earnings, GuidanceSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
